Private sector funded drug spending Canada by top drug classes share 2013
This statistic displays the proportion of the total drug program expenditures in Canada funded by the private sector, by the top 10 drug classes in 2013. In that year, 6.3 percent of total drug program spending funded by the private sector was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.